ALDH3A2
protein-codingaldehyde dehydrogenase 3 family member A2, the group of Aldehyde dehydrogenases
Gene summary
Aldehyde dehydrogenase isozymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. This gene product catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acid. Mutations in the gene cause Sjogren-Larsson syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- SLS
- ALDH10
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~37.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010031
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010031
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0010031
Submitter: Myriad Women's Health
Inheritance Pattern: AR
Disease ID:MONDO:0010031
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010031
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010031
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Dermatologic; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Medical treatment (eg, with Zileuton) may be beneficial for certain aspects
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ALDH3A2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000382.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 181 | 187 | ||
| missense | 6 | 28 | 126 | 17 | 177 | |
| nonsense | 17 | 22 | 39 | |||
| start loss | 1 | 4 | 5 | |||
| frameshift | 57 | 40 | 2 | 99 | ||
| splice donor/acceptor (+/-2bp) | 6 | 22 | 4 | 32 | ||
| Total | 87 | 117 | 137 | 198 | 0 | 539 |
Highest pathogenic variant AF is 0.00009850996
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000373.1 | 10 | MANE Select | |
| Ensembl | ENSP00000176643.6 | 10 | MANE Select | |
| RefSeq | NP_001026976.1 | 10 | Standard | |
| RefSeq | NP_001356065.1 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Tryptophan metabolism - Homo sapiens (human)
- Pyruvate metabolism - Homo sapiens (human)
- Arginine and proline metabolism - Homo sapiens (human)
- Glycolysis / Gluconeogenesis - Homo sapiens (human)
- Glycerolipid metabolism - Homo sapiens (human)
Biological Process
- fatty acid alpha-oxidation
- cellular aldehyde metabolic process
- central nervous system development
- peripheral nervous system development
- epidermis development
Molecular Function
- 3-chloroallyl aldehyde dehydrogenase activity
- aldehyde dehydrogenase (NAD) activity
- protein binding
- protein homodimerization activity
- glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity
Cellular Component
- peroxisomal membrane
- endoplasmic reticulum membrane
- integral component of membrane
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000339618
- Coding exons
- 10
- Length
- 29463
- Individuals with no LoFs
- 125681
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 67
- Defined
- 125748
- p
- 0.000266
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.682 | 245 | 277 | 0.885 | 0.0000151 | 3313 |
| Missense (PolyPhen) | 63 | 94.204 | 0.66876 | 1141 | ||
| Synonymous | 1.53 | 85 | 105 | 0.810 | 0.00000597 | 1007 |
| Loss of Function | 2.21 | 12 | 23.6 | 0.509 | 0.00000111 | 293 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00075 | 0.00075 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00024 | 0.00024 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acids. Active on a variety of saturated and unsaturated aliphatic aldehydes between 6 and 24 carbons in length (PubMed:9133646, PubMed:22633490, PubMed:25047030). Responsible for conversion of the sphingosine 1-phosphate (S1P) degradation product hexadecenal to hexadecenoic acid (PubMed:22633490). {ECO:0000269|PubMed:22633490, ECO:0000269|PubMed:25047030, ECO:0000269|PubMed:9133646}.;
Recessive Scores
- pRec
- 0.338
Intolerance Scores
- LoFtool
- 0.251
- RVIS EVS
- -0.11
- RVIS percentile EVS
- 45.36
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.397
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |